News

Sun Pharmaceutical said that these generic Bupropion Hydrochloride extended release tablets are equivalent to GlaxoSmithKline’s Wellbutrin SR extended release tablets and includes three strengths: 100mg, 150mg and 200mg.

Swedish Orphan Biovitrum is expected to distribute Willfact in Germany, Sweden, Norway, Iceland, Denmark, Estonia, Latvia, Lithuania, Czech Republic, Slovakia, Hungary and Bulgaria, under the agreement with LFB.

EndoChoice said that its GI diagnostics division offers the broad range of diagnostic products and services in the industry, including anatomic pathology services, immunochemical fecal occult blood tests

The new representation centre is expected to intensify Gerresheimer’s business in pharmaceutical primary packaging and drug-delivery systems. Gerresheimer said that the regional representation is expected to contribute to

Brentuximab vedotin is an antibody-drug conjugate (ADC) targeted to CD30, which is expressed on malignant Hodgkin lymphoma cells. The Phase III trial, also known as Aethera, is expected

Vivalis said that the milestone recognises the completion of the characterisation program of the EB66 cell line according to the current regulatory requirements. The worldwide collaboration and license

Pharmasset has recently filed an Investigational New Drug Application (IND) with the FDA. Pharmasset said that Purine nucleoside/tide analogs have many of the benefits of pyrimidine nucleoside/tide analogs,

Emerging World Pharma focuses its investments on generic pharmaceutical companies that have contracts with three major buyer groups; church, government and wholesalers. The investment would entitle Emerging World

The program entitled ‘Sage Integrative Bionetwork Community: Scalable Resource for the State of Washington’ intends to build and deploy a network data management system, that will be a